TrialBritish journal of clinical pharmacology2019

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.

Li-Ming Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.